In vitro anti-HIV activity of phosphoprothioate α-anomeric oligodeoxynucleotides : J.-L. Imbach, B. Rayner, F. Morvan (Laboratoire de Chimie Bio-Organique, U.A. 488 du CNRS, Université de Montepellier II, Sciences et Techniques du Languedoc, 43095 Montepellier Cedex 5, France), M. Matsukara (Department of Pediatrics, Kumamoto University, Medical School, 1-1-1 Honjo, Kumamoto City, 860 Japan) and J.S. Cohen (Clinical Pharmacology Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, MO 20892, U.S.A.)